This company has shut down. Satellos Bioscience is no longer operating — its last tracked round was a Post-IPO Equity in 2025.
Explore the Startup GraveyardSatellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
Satellos Bioscience has raised $754K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2025.
Satellos Bioscience's investors include Perceptive Advisors, Avidity Partners, Soleus Capital, Qiming Venture Partners USA, Bloom Burton & Co..
Satellos Bioscience is headquartered in Toronto, Canada.
Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.
Satellos Bioscience is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Satellos Bioscience — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/satellos-bioscience. Accessed July 19, 2026.
VCBacked. (2025). Satellos Bioscience — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/satellos-bioscience
{{cite web |title=Satellos Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/satellos-bioscience |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated